GEMC-511687777983637
Awarded to Synergy Associates
₹88,500
Products
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| ROSUVASTATIN 10MG+ EZETIMIBE 10MG TAB | LUPIN LIMITED / NOVASTAT EZ TAB | 30049099 | 10,000 tablet(s) | 8.85 | 88,500 |
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | EVEREST PHARMA AGENCIES | Awarded | 1 | ₹31,200 |
| 2 | Schedule 2 | EVEREST PHARMA AGENCIES | Awarded | 1 | ₹1.3 L |
| 3 | Schedule 3 | Synergy Associates | Awarded | 1 | ₹88,500 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
2 Sept 2023, 4:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
ROSUVASTATIN 5MG TAB (Q3)
ROSUVASTATIN 10MG TAB (Q3)
ROSUVASTATIN 10MG+ EZETIMIBE 10MG TAB (Q3)
5138473
GEM/2023/B/3790097
Two Packet Bid
ROSUVASTATIN 5MG TAB,ROSUVASTATIN 10MG TAB,ROSUVASTATIN 10MG+ EZETIMIBE 10MG TAB
GeM Contract
180 days
Odisha; Koraput
Item wise evaluation
PRODUCT_CUSTOM
Awarded to Synergy Associates
₹88,500
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| ROSUVASTATIN 10MG+ EZETIMIBE 10MG TAB | LUPIN LIMITED / NOVASTAT EZ TAB | 30049099 | 10,000 tablet(s) | 8.85 | 88,500 |
Awarded to EVEREST PHARMA AGENCIES
₹1.6 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| ROSUMAC 10 | ROSUMAC 10/MACLEODS / MACLEODS | HSN not specified by seller | 60,000 tablet(s) | 2.16 | 129,600 |
| ROSUMAC 5 | ROSUMAC 5 / MACLEODS / MACLEODS | HSN not specified by seller | 20,000 tablet(s) | 1.56 | 31,200 |
3 documents required · 3 mandatory
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| ROSUVASTATIN 5MG TAB (Q3) | - | - | - |
| ROSUVASTATIN 10MG TAB (Q3) | - | - | - |
| ROSUVASTATIN 10MG+ EZETIMIBE 10MG TAB (Q3) | - | - | - |
Exempted
5 Jan 2024
12 Aug 2023
2 Sept 2023
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_5138473.pdf
GEM_BID
01_rfq-6000061640_2023-08-05-12-26-33_d3e6f14dbe0b0131abbfcef56afbe3d1.pdf
SPECIFICATION
02_rfq-6000061640_2023-08-05-12-28-18_645cdc7355f27a1f2ba86593e910c345.pdf
SPECIFICATION
03_rfq-6000061640_2023-08-05-12-31-49_5d0a83d589fb5a3b4dea7bec218695ab.pdf
SPECIFICATION
SA8000Med_b1d69a57-76e4-4dc6-a6461691220167981_ahemanth.docx
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .